Drug development

#Drug development #Drug discovery #Lab automation #Laboratory #Research services #Technology

What technologies are enabling drug discovery breakthroughs?

Download our latest eBook ‘Technology in the lab: what’s enabling drug discovery?’ sponsored by Analytik Jena. The eBook features insights and expert opinions on the solutions and technologies that are enabling drug discovery breakthroughs and assisting research and development. Download now to learn more about: The solutions helping drug… Read More

#News

#Drug development #Drug discovery #Lab automation #Laboratory #Research services #Technology

Technology in the lab: what’s enabling drug discovery?

This latest eBook sponsored by Analytik Jena features insights and expert opinions on the solutions and technologies that are enabling drug discovery breakthroughs and assisting research and development. Download this exclusive eBook to learn more about: The solutions helping drug discovery breakthroughs get to market faster and more efficiently The… Read More

#DDW eBooks #Intelligence

#AAV #Advanced Therapies #CAR-T #Cell and gene therapy #Cell therapy #Drug development #Drug discovery #Gene therapy #RNA

Keep up to date: DDW Highlights 30 January 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  Cell and gene therapies have been making the news this week, as… Read More

#News

#Drug development #Drug discovery #Life sciences #Lithuania #Start-ups

What Lithuania offers life sciences start-ups

Listen to this article on the DDW Podcast: DDW Editor Reece Armstrong takes a look at Lithuania’s life sciences sector and what it means for start-ups operating in the country. A one to watch, would be my first thoughts when thinking about Lithuania and its start-up sector. After a visit to the… Read More

#Exclusive Content #Start-up Zone

#Cell and gene therapy #Drug development #Drug discovery #Webinar

Webinar: Transforming disease treatment with CGT

Register to attend Cell and gene therapy: sustaining growth and maximising opportunities, a free-to-attend DDW webinar, supported by Benchling and BPS Bioscience, on February 17, 2023 at 8am PST / 11am EST / 4pm GMT / 5pm CET.  Cell and gene therapies (CGT) are transforming the way diseases… Read More

#News

#AAV #Advanced Therapies #CAR-T #Cell and gene therapy #Cell therapy #Drug development #Drug discovery #Gene therapy #RNA

This week in drug discovery (23-27 January)

News round-up for 23-27 January by DDW Digital Content Editor Diana Spencer. Cell and gene therapies have been making the news this week, as we launch our very own guide to global… Read More

#News

Protein degradation
#Biology #CRO #Drug development #Drug discovery #Genomics #Protein chemistry / Proteomics #Therapeutics

New podcast on CROs and targeted protein degradation

This is the latest episode of the free narrated DDW podcast, “CROs and targeted protein degradation offer an exciting future”. It covers two articles written for Volume 23, Issue 1 – Winter 2021/22 of DDW. They are called “CROs: Drug discovery expertise on hand” and “Why the emergence… Read More

#News

#Cell and gene therapy #Drug development #Drug discovery #Webinar

Learn about sustaining growth and maximising opportunities in CGT

Cell and gene therapies (CGT) are transforming the way diseases are treated. As research progresses it is hoped that cell and gene therapies will offer innovation for the future. Join this free webinar, hosted by DDW and supported by BPS Bioscience and Benchling, to learn… Read More

#News

#Cell and gene therapy #Drug development #Drug discovery

Cell and gene therapy: sustaining growth and maximising opportunities

Cell and gene therapies are transforming the way diseases are treated. As research progresses it is hoped that cell and gene therapies will offer innovation for the future. In this on-demand webinar you will hear from CBO/CDO of Adthera Bio, Stuart Curbishley, Chief Executive Officer of Cell & Gene Therapy… Read More

Webinar date:
Sponsored by Benchling and BPS Bioscience
#Webinars

#AI #Antimicrobial resistance (AMR) #Bioscience #Drug development #Europe #Phage therapy #Research

Grant will allow development of phage therapy diagnostic platform 

Vésale Bioscience, a company in the research and development of solutions and treatments using phage therapy for multi-resistant infections, has received €1.8 million in grants from the European Innovation Council (EIC) Accelerator Fund for its PhageDiag project.  The project is a phagogram using artificial intelligence (AI) that… Read More

#News

#Cell and gene therapy #Cell therapy #Drug development #Drug discovery #Gene therapy #Guide

Exclusive insight into cell and gene therapy

Download this exclusive cell and gene therapy guide to learn about: The successes of cell and gene therapies plus the biggest questions facing the sector Expert views on the challenges and opportunities for cell and gene therapies in 2023 Understanding future road maps of cell and gene therapies Why there… Read More

#DDW eBooks

#Cell and gene therapy #Drug development #Drug discovery #Guide

Latest DDW Guide: Exclusive insight into cell & gene therapy

DDW has published the first of its new Guide Series, Where is the global innovation and the opportunity in cell and gene therapy? It is sponsored by Astrea BioSeparations and Benchling.  In this free, exclusive guide, you will learn more about:  The successes… Read More

#News

#Cancer research #Clinical trials #Drug development #Drug discovery #Phase I trial #Phase II trial #Phase III trial

DDW Highlights podcast: 23 January 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  Clinical trials have led our news section this week, with positive results… Read More

#News

#Clinical trials #Drug development #EU #FDA #Regulatory

Regulatory affairs in 2023: Key trends and changes  

Dr Julie Warner is Vice President of Regulatory Affairs at global drug development consultancy, Boyds. In this article, she provides her expert insights into the key regulatory developments likely to shape the global drug development industry this year.    Implementation of the EU Clinical Trials Regulation  The way clinical trials (CTs)… Read More

#Business & Investment #Exclusive Content #Opinion #Regulatory #Trends & Analysis

#Cancer research #Clinical trials #Drug development #Drug discovery #Phase I trial #Phase II trial #Phase III trial

This week in drug discovery (16-20 January)

News round-up for 19-20 January by DDW Digital Content Editor Diana Spencer. Clinical trials have led our news section this week, with positive results announced from several Phase I and II studies. There was good news from Alto Neuroscience, everImmune, Avacta and Abionyx, though unfortunately things are not… Read More

#News

#Cancer research #Drug development #Drug discovery #Guide #Oncology #Precision medicine

Trends in precision medicine: Cancer

This is an extraordinarily exciting time to be involved in precision medicine for cancer. This new whitepaper reviews some of the topics and trends in this emerging research area, including: 3D cultures: Spheroids and organoids Organoids in cancer research Tumour microenvironments Organ-on-a-chip and body-on-a-chip 3D bioprinting… Read More

#Resources